Fifarma
Membership Organizations · Mexico · 11-50 Employees
View Company Info for Free
Overview
Headquarters
No. 102 Av Porfirio Díaz, Mexico City, M...Website
www.fifarma.orgRevenue
<$5 MillionIndustry
About Fifarma
Fifarma Org Chart
Director, Health Policy
Director, DE Asuntos Regulatorios Regulatory ...
Is Fifarma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Fifarma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Fifarma
Funding: Get notified immidiatlly once Fifarma has new funding data
Website visits: Recent activity has been detected on your website
Fifarma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Fifarma is spiking on competitors!
Check if Fifarma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Fifarma launches new products
Click to see if Fifarma had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Fifarma
Find 2 more new buyers
Company Profile Activity
Activity Insights
Fifarma is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Fifarma is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Fifarma.
Fifarma Tech Stack
A closer look at the technologies used by Fifarma
Fifarma News & Media
Top Membership Organizations Companies
Frequently Asked Questions Regarding Fifarma
Fifarma is the Latin American Federation of the Pharmaceutical Industry, uniting local associations and research and development pharmaceutical companies across Latin America and the Caribbean. The organization focuses on promoting scientific research and patient well-being while advocating for access to innovative treatments and the recognition of... Read More